Are medical oncologists biased in their treatment of the large woman with breast cancer?
- 1 March 2001
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 66 (2) , 123-133
- https://doi.org/10.1023/a:1010635328299
Abstract
Purpose.Obesity and breast cancer are common conditions that often coexist. Concerns of relative overdosing of chemotherapy in the large cancer patient have led clinicians to apply empiric dose...Keywords
This publication has 29 references indexed in Scilit:
- Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast CancerNew England Journal of Medicine, 2000
- Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancerEuropean Journal Of Cancer, 1998
- Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Predicting body fatness: the body mass index vs estimation by bioelectrical impedance.American Journal of Public Health, 1995
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Individual dose adaptation of anticancer drugsEuropean Journal Of Cancer, 1994
- Is body composition an important variable in the pharmacokinetics of anticancer drugs?Cancer Chemotherapy and Pharmacology, 1994
- Body size and breast cancer prognosis: A critical review of the evidenceBreast Cancer Research and Treatment, 1990
- Is Dose Normalization to Weight or Body Surface Area Useful in Adults?JNCI Journal of the National Cancer Institute, 1990
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981